نوع مقاله : Original Article(s)
نویسنده
مرکز ملی تحقیقات بیمه سلامت مرکز تحقیقات غدد و متابولیسم، دانشگاه علوم پزشکی اصفهان، اصفهان، ایران.
چکیده
تازه های تحقیق
سید مسعود شجری پور موسوی: Google Scholar, PubMed
منصور سیاوش: Google Scholar, PubMed
مجتبی اکبری: Google Scholar, PubMed
کلیدواژهها
موضوعات
عنوان مقاله [English]
نویسنده [English]
Introduction: Clinical laboratory tests are vital for disease diagnosis, but their prescribing patterns vary regionally due to economic and infrastructural factors. This study analyzed test utilization patterns and economic impacts in Iran over 8 years.
Methods: Data included 3.9 billion tests (cost: 17.8 trillion IRR) from 31 provinces. Key tests (TSH, CBC, glucose, creatinine, UA, 25-OH Vit D) were analyzed. K-Means Regional Patterning, ANOVA, and PCA were applied using Python/Scikit-learn.
Results:
• Regional Pattern 1 (7 provinces: Tehran, Khorasan Razavi, Fars, West Azerbaijan, Gilan, Hamedan, Yazd): 39% population; high TSH (8-10%) and 25-OH Vit D (5-12%), indicating thyroid/vitamin D screening.
• Regional Pattern 2 (9 provinces: Isfahan, Alborz, East Azerbaijan, Ardabil, Zanjan, Semnan, Ilam, Bushehr, North Khorasan): 19.2% population; elevated glucose (5-6%) and creatinine (5%), linked to diabetes/kidney diseases.
• Regional Pattern 3 (10 provinces: Khuzestan, Kerman, Sistan-Baluchestan, Kurdistan, Golestan, Qazvin, Kermanshah, Chaharmahal-Bakhtiari, Kohgiluyeh-Boyer Ahmad, South Khorasan): 29.7% population; high CBC (7-8%), suggesting hematologic disorders.
• Regional Pattern 4 (5 provinces: Mazandaran, Qom, Lorestan, Markazi, Hormozgan): 12.1% population; moderate screening-focused patterns (3-5%). Differences were significant (p < 0.05).
Conclusion: Regional disparities highlight the need for targeted policies to optimize test utilization and equity.
کلیدواژهها [English]
)